Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FZH83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,207
Award facts
- Contract value 100% obligated
- $14,207.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,207.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, contains no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This award represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division, demonstrating the company's competitive capability in pharmaceutical supply to the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V initiative positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supplying military healthcare facilities worldwide with both branded and generic medications, biologics, vaccines, and specialty pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB26FZH83?
SPE2DB26FZH83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FZH83 worth?
The government has obligated $14,207 on SPE2DB26FZH83.
Is contract SPE2DB26FZH83 an order under another contract?
Yes. SPE2DB26FZH83 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB26FZH83 competed?
The extent of competition for SPE2DB26FZH83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award